Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer

Open Access

Peer-reviewed

Research Article

Kendall Phelps-Polirer,

Affiliation Department of Health Sciences, Clemson University, Columbia, SC, United States of America
⨯
Melissa A. Abt,

Affiliation Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States of America
⨯
Danzell Smith,

Affiliation Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States of America
⨯
Elizabeth S. Yeh

* E-mail: yeh@musc.edu

Affiliation Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States of America
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Autophagic cell death
Is the Subject Area "Autophagic cell death" applicable to this article?

Thanks for your feedback.
Chloroquine
Is the Subject Area "Chloroquine" applicable to this article?

Thanks for your feedback.
BT474 cells
Is the Subject Area "BT474 cells" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Signal inhibition
Is the Subject Area "Signal inhibition" applicable to this article?

Thanks for your feedback.